| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/05/1992 | WO1992003410A1 N-(mercaptoalkyl)ureas and carbamates |
| 03/05/1992 | WO1992003155A1 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa |
| 03/05/1992 | WO1992003151A1 Uses of recombinant colony stimulating factor-1 |
| 03/05/1992 | WO1992003146A1 Therapeutically active mixture of glutathion and anthocyan compounds |
| 03/05/1992 | WO1992003143A1 Central nervous system activator and appetizing food additive |
| 03/05/1992 | WO1992003141A1 Topical compositions and methods for treatment of male impotence |
| 03/05/1992 | WO1992003140A1 Enzymic alteration of hair growth |
| 03/05/1992 | WO1992003139A1 Oligonucleotide modulation of cell adhesion |
| 03/05/1992 | WO1992003137A1 Treatment of aids dementia, myelopathy, peripheral neuropathy, and vision loss |
| 03/05/1992 | WO1992003135A1 Pharmaceutical compositions containing 5-difluoromethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl] benzimidazole and an anti-helicobacter agent for the treatment of gastrointestinal disorders |
| 03/05/1992 | WO1992003133A1 Topical treatment of blepharitis |
| 03/05/1992 | WO1992003130A1 Use of aryl hydroxyurea compounds for the treatment of atherosclerosis |
| 03/05/1992 | WO1992003128A1 Pharmaceutical compositions with mucolytic and antitussive activity containing (-)-trans-sobrerol |
| 03/05/1992 | WO1992003127A1 Compositions and methods for treating hiv infections |
| 03/05/1992 | WO1992003126A1 Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure |
| 03/05/1992 | WO1992003052A1 Method for suppression of hiv replication by ascorbate for chronic and acute hiv infection |
| 03/05/1992 | WO1992003049A1 Methods and compositions for treating t-cell mediated diseases |
| 03/05/1992 | WO1992000074A3 Pyridopyrazine derivatives for treating substance abuse and addiction |
| 03/05/1992 | WO1991019707A3 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones |
| 03/05/1992 | WO1991015200A3 Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases |
| 03/05/1992 | CA2090853A1 Certain cycloalkyl imidazopyrimidines, a new class of gaba brain receptor ligands |
| 03/05/1992 | CA2090689A1 Regulation of t-cell proliferation via a novel 5htla receptor |
| 03/05/1992 | CA2090688A1 Regulation of neoplastic cell proliferation via a novel 5htla receptor |
| 03/05/1992 | CA2089770A1 Heterocyclic compounds and their preparation and use |
| 03/05/1992 | CA2089257A1 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa |
| 03/05/1992 | CA2073051A1 Process for extracting minor fatty compounds which occur in a substance of biological origin |
| 03/05/1992 | CA2073014A1 Process for extracting minor fatty compounds from a substance of biological origin |
| 03/05/1992 | CA2072871A1 Preservation of blood, tissues and biological fluids |
| 03/05/1992 | CA2072749A1 Antimicrobial preservation of plasma |
| 03/05/1992 | CA2050537A1 Hmg-coa reductase inhibitor metabolites |
| 03/05/1992 | CA2050434A1 Renin inhibitors |
| 03/05/1992 | CA2050424A1 2-tert-substituted methyloxapenem-3-carboxylic acids and esters, a process for their preparation and their use |
| 03/05/1992 | CA2048699A1 Method for preventing or treating cerebro-vascular disease employing ceronapril |
| 03/04/1992 | EP0473564A1 Anticoagulant combination of laci and sulfated polysaccharides |
| 03/04/1992 | EP0473550A1 Indolonaphthyridines |
| 03/04/1992 | EP0473442A1 A substituted pyrazine and its salts, compositions containing them and their use in medicine |
| 03/04/1992 | EP0473431A1 Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets |
| 03/04/1992 | EP0473337A2 Nor-statine and nor-cyclostatine polypeptides in the treatment of ocular hypertension and glaucoma |
| 03/04/1992 | EP0473326A1 Water soluble derivatives of taxol |
| 03/04/1992 | EP0473308A1 Aldose reductase inhibitor |
| 03/04/1992 | EP0473285A1 Use of 2-(phenoxypropanolamino)ethoxyphenoxyacetic acid and its derivatives to inhibit gastrointestinal motility |
| 03/04/1992 | EP0473252A2 Use of L-deprenyl for retarding deterioration due to aging in dogs |
| 03/04/1992 | EP0473225A2 Process for iodinating or brominating the alpha-methylenic carbon of a secondary amide |
| 03/04/1992 | EP0473223A1 Bioerodible implants |
| 03/04/1992 | EP0473159A1 Stable aqueous preparation |
| 03/04/1992 | EP0473145A1 Compositions for inhibiting aminoglycoside nephrotoxicity |
| 03/04/1992 | EP0473108A2 Preparation for treating renal disease |
| 03/04/1992 | EP0473024A1 Heterocyclic substituted cycloalkano(b)-indolesulfonamides |
| 03/04/1992 | EP0472969A1 External preparation comprising calcium silicate |
| 03/04/1992 | EP0472725A1 Treatment of polycystic ovarian disease. |
| 03/04/1992 | EP0472663A1 Method of treatment of hepatitis |
| 03/04/1992 | EP0472639A1 Accumulation of drugs into liposomes by a proton gradient |
| 03/04/1992 | EP0472628A1 Use of melatonin derivatives for effecting contraception |
| 03/04/1992 | EP0472595A1 Method of treatment of hepatitis |
| 03/04/1992 | EP0472531A1 Proanthocyanidol-based composition and its pharmacological application. |
| 03/04/1992 | EP0299972B1 Anthelmintic quaternaryalkyl acylhydrazones, method of use and compositions |
| 03/04/1992 | EP0198893B1 Hair growth modification |
| 03/04/1992 | EP0180597B1 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs |
| 03/04/1992 | CN1059150A Steroids and their use as 5 alpha-reductase inhibitors |
| 03/04/1992 | CN1059149A Phospholipid derivatives of nucleosides, processes for prepn. thereof and use thereof as antiviral medicaments |
| 03/04/1992 | CN1059143A Pyrazolopyridine compound and process for prepn. thereof |
| 03/04/1992 | CN1059142A Thiophene derivatives |
| 03/04/1992 | CN1059141A 苯并二氮杂衍生物 Benzodiazepine derivative |
| 03/04/1992 | CN1015714B Prepn. of 7-amino-3-propenylcephalosporanic acid and esters thereof |
| 03/04/1992 | CN1015711B Cycloalkaho (1,2-b) indole-sulphonamides |
| 03/04/1992 | CN1015707B Amide derivatives |
| 03/04/1992 | CA2048043A1 Inhibitory agent of an increase in blood sugar level |
| 03/03/1992 | WO1992003460A1 4-o-(aminoglycosyl)- or 4,6-di-o-(aminoglycosyl)-2,5-dideoxy-5,5-difluorostreptamine derivative and production thereof |
| 03/03/1992 | US5093525 Neuroprotective agents |
| 03/03/1992 | US5093519 Vitamin d derivatives: therapeutic applications and applications to assays of metabolities of vitamin d |
| 03/03/1992 | US5093516 Aromatic compounds, a process for their preparation and their use in human and veterinary medicine and for cosmetic compositions |
| 03/03/1992 | US5093507 Estrenes, antiglucocorticoid, antiestrogen |
| 03/03/1992 | US5093505 Pyranone and pyran-thione derivatives |
| 03/03/1992 | US5093493 Anxiolytic agents, antidepressants |
| 03/03/1992 | US5093372 Used in treatment of dementia, improved solubility, absorption cellulose ethers |
| 03/03/1992 | US5093371 Naphthyl ketone inhibitors of cholesterol esterase and their use as hypolipidemic and hypocaloric agents |
| 03/03/1992 | US5093370 Useful prior to insertion of tracheotomy tube or discission |
| 03/03/1992 | US5093365 Non-β-oxidizable fatty acid analogues with the effect to reduce the concentration of cholesterol and triglycerides in blood of mammals |
| 03/03/1992 | US5093363 2,4,6-substituted phenol derivatives |
| 03/03/1992 | US5093360 Retinal, derivatives and their therapeutic use |
| 03/03/1992 | US5093359 Macrolactone antibiotics |
| 03/03/1992 | US5093354 Topical use of 2',4',6'-trimethoxy-4-(1-pyrrolidinyl) butyrophenone |
| 03/03/1992 | US5093352 Melatonin inhibitor, sleep, 2-aryl N-acetyl tryptamine |
| 03/03/1992 | US5093351 Substituted indole, benzofuran and benzothiophene derivatives as 5-lipoxygenase inhibitors |
| 03/03/1992 | US5093350 Dehydrocycloclausenamide, its preparation and use in treating cerebral hypoxia |
| 03/03/1992 | US5093348 Pharmaceutical composition for topical ophthalmic use having improved local tolerability |
| 03/03/1992 | US5093343 Substituted 1,3,4-oxa (thia) diazolinones process for their preparation and their use of combating endoparasites |
| 03/03/1992 | US5093342 Use of omeprazole as an antimicrobial agent |
| 03/03/1992 | US5093341 N-aralkyl piperidine derivatives useful as antithrombolytic agents |
| 03/03/1992 | US5093340 Lipoxygenase enzyme inhibitors, antithrombolytic agents |
| 03/03/1992 | US5093339 Anticoagulant, hypotensive, antiangina, antiasthma, antiulcer, anti-platelet activating factor |
| 03/03/1992 | US5093338 Lipophilic macrolide useful as an immunosuppressant |
| 03/03/1992 | US5093337 Substituted derivatives of 20,21-dinoreburnamenine, their use as medicaments and the pharmaceutical compositions containing them |
| 03/03/1992 | US5093336 Treatment of cardiac failure and memory deficit |
| 03/03/1992 | US5093334 Dermal treatment of worm diseases in cats with praziquantel |
| 03/03/1992 | US5093333 N-substituted-2-aminoquinolines useful for treating hypofunction of the cholinergic system |
| 03/03/1992 | US5093332 Substituted thieno(2,3-b)(1,4)thiazine-6-sulfonamides as antiglaucoma agents |
| 03/03/1992 | US5093331 Inotropic, hypotensive, glaucoma |
| 03/03/1992 | US5093329 Intraocular pressure reducing prostaglandin-like 7-oxabicyclo derivatives |
| 03/03/1992 | US5093325 Combination preparation having antithrombotic action |